Immunosuppressive therapy in the rheumatic diseases.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000505:Alopecia / Q000139:chemically induced; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy*; D001855:Bone Marrow Diseases / Q000139:chemically induced; D056486:Chemical and Drug Induced Liver Injury; D002986:Clinical Trials as Topic; D003556:Cystitis / Q000139:chemically induced; D005260:Female; D006562:Herpes Zoster / Q000150:complications; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007231:Infant, Newborn; D007239:Infections / Q000150:complications; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D009393:Nephritis / Q000188:drug therapy; D010919:Placebos; D011247:Pregnancy; D011658:Pulmonary Fibrosis / Q000139:chemically induced
D007166:Immunosuppressive Agents; D010919:Placebos